Navigation Link
Drug Addiction
Basic InformationLatest News
'Cannabis Use Disorder' Up in States That Legalized Recreational PotOne Region Is Being Hit Hardest by U.S. Opioid CrisisHealth Tip: Medication and Substance Abuse RecoveryBeating Opioid Addiction Can Be Tough, Here's What HelpsComing Soon: A 'Pot Breathalyzer'?U.S. Opioid Deaths Take a Small Dip, as Fentanyl Leaves Deadly MarkOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid Claims'Synthetic Pot' Laced With Rat Poison Lands People in the ERJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisAmerica Has a Huge -- and Very Costly -- Drug HabitAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesLethal Deception: Deaths From Cocaine Laced With Fentanyl on the RiseMany Young Americans Regret Online Posts Made While HighToo Few U.S. Opioid Users Are Getting OD AntidoteDrug Experimentation and Summer a Dangerous DuoMedical Marijuana Won't Help Ease Opioid Crisis: StudyOpioid Epidemic Doubled Number of U.S. Kids Sent to Foster CareKeep Unused Meds Out of the Hands of AddictsFDA Warns Two Kratom Marketers About False ClaimsFatal Opioid ODs Rise as Temperatures FallDrug ODs, Suicides Soaring Among Millennials: ReportLegalizing Medical Pot Won't Ease Opioid Crisis: StudyDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study Shows'Secret Shopper' Study Finds Many Who Need Addiction Treatment Can't Get ItHealth Tip: Naloxone Fast FactsCould CBD Treat Opioid Addiction?Heroin ODs Have Started Declining in Some StatesQuantity, Not Type of Opioid Matters for Post-Op DependencyMore Than 600,000 Opioid Abusers Raising Kids in U.S.Many Drug Abusers Use Family Members to 'Opioid Shop'Poor, Minorities Shortchanged on Opioid Addiction TreatmentsDispensing Opioid Antidote Without a Prescription Might Save LivesFentanyl Becoming a Deadly Accomplice in Cocaine, Meth AbuseNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMany Drivers Testing Positive for Marijuana, Even With Kids in CarFDA Approves 1st Generic Nasal Spray Against Opioid OverdoseAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsIn Most States, Insurance Won't Cover Addiction TreatmentsOverdose Deaths From Fentanyl Soaring: ReportMany With Opioid Addiction Don't Get Meds That Can HelpVets Who Get Opioids From VA, Medicare at Higher Overdose RiskU.S. Deaths From Suicide, Substance Abuse Reach Record HighOpioid Overdose Deaths Quadruple, Centered in 8 StatesAmong Rich Nations, U.S. Has Highest Rate of Fatal Drug ODsFDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindOpioid Addicts Are Overdosing on Diarrhea DrugMaking OxyContin 'Tamper Proof' Helped Spread Hepatitis C
Related Topics

Many Addiction Centers Lack Anti-Opioid Meds: Study

HealthDay News
by By Alan Mozes
HealthDay Reporter
Updated: Jan 22nd 2019

new article illustration

TUESDAY, Jan. 22, 2019 (HealthDay News) -- Although the U.S. opioid epidemic dates back more than a decade, only 6 percent of treatment centers in 2016 offered the three medications approved to treat opioid addiction, new research reveals.

And only about a third offered even one of the three recommended drugs, the study found.

"The country is dealing with an opioid overdose death epidemic," said study lead author Dr. Ramin Mojtabai, a professor of mental health at the Johns Hopkins School of Public Health in Baltimore.

"Attention to medication treatment for opioid use disorders can help to curb this epidemic," along with distribution of opioid-blocking naloxone kits to prevent OD deaths, he said.

Buprenorphine, naltrexone and methadone are approved by the U.S. Food and Drug Administration for long-term treatment of opioid use disorder, including addiction to prescription painkillers and heroin. But many centers still rely on talk therapy to promote abstinence.

Mojtabai and his team analyzed national surveys of 10,000 outpatient centers conducted by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) between 2007 and 2016.

On the upside, just 20 percent of facilities offered at least one opioid treatment medication in 2007, but that figure was 36 percent in 2016.

However, "only a small fraction offered all three," said Mojtabai.

Methadone and buprenorphine are so-called agonists that attach to opioid receptors in the brain and reduce craving, Mojtabai explained. Naltrexone, an extended-release antagonist, is injected monthly to block opioid receptors and curtail any "high."

The findings didn't surprise Lindsey Vuolo, associate director of health law and policy at the Center on Addiction in New York City.

"We know that only one to two in 10 people receive any treatment for their substance use disorder, and that only a fraction of the people receiving addiction treatment receive these medications," Vuolo said.

These medications help, she added.

"Overall, approximately 50 percent of patients who receive medications for opioid addiction are successfully treated, while less than 10 percent of patients are successfully treated without these medications," said Vuolo, who was not involved in the study.

According to the U.S. Centers for Disease Control and Prevention, drug overdose deaths involving opioids topped 47,000 in 2017.

Whether treatment options have improved since 2016, when the study ended, isn't known.

"It is quite possible that with growing attention and funding, facilities are doing a better job at providing these vital treatments in more recent years," Mojtabai said. He mentioned the launch of new SAMHSA opioid crisis grants as an example of progress.

But Vuolo cautioned that while treatment access has increased in states such as Rhode Island and Vermont, growth has unfolded unevenly across the country.

"The number of people receiving treatment has not changed significantly, even in light of the unrelenting opioid epidemic," she said.

"I don't think research will show significant changes between 2016 and 2019 on a national scale," Vuolo noted.

Mojtabai believes "there are probably multiple reasons" why opioid medication access has been limited.

"State Medicaid programs vary with regard to covering these medications," he said. "Also, facilities need to have providers that can prescribe buprenorphine. Hiring such providers is costly."

It's also possible there still are concerns about using medications to treat drug abuse, despite strong evidence of their effectiveness and safety, Mojtabai added.

Vuolo said changes in clinical rules since 2016 have expanded the pool of caregivers who can prescribe opioid treatments. In addition, 254 new opioid treatment programs opened between 2014 and 2018.

But she characterized such developments as "pretty small, incremental improvements."

The "lack of access to these medications is one of the major reasons we continue to see so many people dying from opioid overdoses," Vuolo said.

The study findings are in the January issue of Health Affairs.

More information

The U.S. National Institute on Drug Abuse has more on the U.S. opioid crisis.